Skip to content
SignaBlok
  • News & Publications
    • News
    • Publications
  • Contact Us
  • About Us
    • History
    • Patents
  • Technology
    • Signaling Chain HOmoOLigomerization (“SCHOOL”) Platform Basics
    • Macrophage Modulation
    • Macrophage Imaging
  • Pipeline
  • Therapeutic Areas
    • Cancer
    • Autoimmune Diseases
    • Retinopathy
    • Atherosclerosis
    • Sepsis/ARDS & COVID
    • Other Inflammatory Diseases
  • Partners & Collaborators
Menu
Understanding Nature. Improving Life
Type and press enter to search

History

SignaBlok > About Us > History
SignaBlok > About Us > History

Print

  • About Us
  • History
  • Patents

“SCHOOL”: Signaling Chain HOmoOLigomerization

This discovery opens new avenues for drug development with applications in many serious diseases.

Read More

Publications

Check our latest News and Publications

Read More

SignaBlok, Inc.
P.O. Box 4064
Shrewsbury, MA 01545
USA

info@signablok.com

  • About Us
  • History
  • Patents
  • News & Publications
  • News
  • Publications
  • Technology
  • Signaling Chain HOmoOLigomerization (“SCHOOL”) Platform Basics
  • Macrophage Modulation
  • Macrophage Imaging
  • Signablok
  • Pipeline
  • Partners & Collaborators
  • Contact Us
  • Sitemap
  • Therapeutic Areas
  • Cancer
  • Autoimmune Diseases
  • Retinopathy
  • Atherosclerosis
  • Sepsis/ARDS & COVID
  • Other Inflammatory Diseases
© Copyright . All Right Reserved
Website by Axxiem
Scroll to top
close ×
Full View Full View